Member Info for K3VMC

50% higher than the current sp, AFTER announcing ground-breaking access to 100m UK bank accounts

Dumb PIs selling down here. Doh!!!

I hope tomorrow’s RNS is a deal with UBS, to access every other EU accounts. That’ll learn

‘em!

Is it really that hard!

COLINB1007

“ Big world out there K3. GL”

Agreed. But Conister bank is the ONLY bank it needs in the UK. Conister gets an infinite increase in its overdraft business, without incurring the massive overheads of the Big Five banks. Undercut their overdrafts rates with a seamless, online offering.

Fiinu has a UNIQUE product, guaranteed to benefit from hundreds of thousands of new overdrafts, in very short order.

DRCed

“ The three year exclusivity element is the issue that may cause concern for some people.”

Fiinu would have to be stupid to tie itself to one bank for more than three years. It could very easily get its own banking licence within that time. This is just a very quick route to market and profitability.

Why do you think they managed to raise at a 33% premium yesterday?

COLINB1107

“ Just the start, might not be one of the big banks we were all hoping for but it’s the beginning with more to come.”

Jebus wept!!!

THERE IS NO OTHER BANK. THAT’S THE WHOLE POINT OF THE RNS!!!

Conister Bank, CEO Jim Mellon, provides the regulatory framework work, as a bank, to provide overdrafts to holders of every single bank account at in the UK and most of the EU.

That’s the unique position they have. They can give overdrafts to anyone with a bank account, cheaper than the customer’s own bank!!!

Jim Mellon is a billionaire for good reasons!

Https://ffnews.com/newsarticle/funding/fiinu-plc-looks-to-raise-1-41-million-through-a-targeted-fundraise-and-welcome-qvp-luxembourg-as-key-investor/

Tree shakers, eh?

Fiinu Plc (AIM: BANK), is pleased to announce that it has entered into subscription agreements to raise gross proceeds of up to £900,000 through the issue of 4,500,000 new ordinary shares at 20 pence per share (the "Subscription Shares"). The Subscription Shares will be issued, in response to market demand, and the funds raised will be utilised to provide additional working capital for the Group.

100m bank account holders, at a time when tens of millions have to rely on overdrafts.

What don’t you understand about the unique competitive advantage here?

Tonnacombe

“ And before everyone kicks off nobody on this BB has ever said oh i hope it's Conister bank. Pah”

I’m probably one of the 0.1% of investors who know Conister Bank. The reality is, Conister has a UK banking licence and Open Banking access.

The didderence between Conister and the big banks, is that Conister will take business AWAY from the big banks. The financial incentive is huge for them.

Brilliant move and a company maker for Fiinu.

SteveWilliams

“ No brainer”

Have to agree with you there. 23% holders, some of them down 90%, called time on the old guard. Rightly so.

Still the only FDA appliance approved for CTC harvesting, which will be CRUCIAL to support the development and testing of cancer therapies of the future, as evidenced by 145 peer-reviewed publications on efficacy and importance. There will be many pharma contracts up for grabs, all extremely lucrative. The first one to drop will 10x the sp. Non-dilutive fundraising will do likewise. Even hiring suitable replacements for AN and IG should put a light under it.

Everything to play for.

1.75p.

Nice pullback. Time to go again.

3.3p

IWWTBOOTOTW

😃

Three holders have 22% of AGL.

If you think they will countenance a discounted placing, you need to think again.

Profit!!

RSI over 50.

Gordon

“ Not sure what value you think there is left here.”

If you can’t imagine what any substantive pharma deal would do to the sp, you should not be investing. That presumes you invest in anything and don’t just troll boards for kicks.

PM01

My thoughts exactly! Creators have special attachments to their projects. I can imagine AN has been dreaming of his astounding success for many, many years. His ego was probably too integrated with Angle’s acclaim and riches to come, as he saw it.

I agree with the view that AN and IG would not have been demoted, unless Cavendish and the major shareholders had already identified their successors, who will be more interested in getting a chance to run with the unique technology, get a decent salary and absolutely millions of options, than massaging their egos. There must be lots of potential heroes currently working for pharma, or with medical device companies.

Somebody from Roche Diagnostics for example, would be ideal.

Imagine what a suitable worded RNS on Monday might do to the sp.

EmeraldCarrots

“ If they want to add CTC DNA analysis to their menu why not buy Angle?”

With AN gone, they may want to try that, but with three shareholders holding 70m+ shares, probably 30-50p average, I would hope they have to pay a decent price for the business.

I remember AN buying 125/- at 80p.

You would think he should be buying a few more down here.

10:04:54 BSTGBX1.415p. 1,000,000. £14,150.00

10:04:39 BSTGBX1.4p. 1,000,000. £14,000.00

There won’t be any rivals in this space.